Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives Consensus “Hold” Recommendation from Analysts

0

Shares of Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) received an average rating of “N/A” from the thirteen analysts currently covering the stock, MarketBeat.com reports. The 12-month average price target among analysts who have reported on the stock over the past year is €65.62 ($71.33).

A number of equity analysts have weighed in on FME shares. JPMorgan Chase & Co. set a target price of €48.70 ($52.93) on Fresenius Medical Care AG & Co. KGaA in a Monday, March 21 research report. Credit Suisse Group set a target price of €61.00 ($66.30) on Fresenius Medical Care AG & Co. KGaA in a Monday, February 28 research report. Berenberg Bank set a target price of €83.40 ($90.65) on Fresenius Medical Care AG & Co. KGaA in a Wednesday, March 23 research report. Kepler Capital Markets set a target price of €59.00 ($64.13) on Fresenius Medical Care AG & Co. KGaA in a Monday, January 10 research report. Finally, Barclays set a target price of €70.00 ($76.09) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, February 22 research report.

ETR FME open at €62.56 ($68.00) on Mondays. Fresenius Medical Care AG & Co. KGaA has a 12 month minimum of €50.98 ($55.41) and a 12 month maximum of €71.14 ($77.33). The stock has a market capitalization of $18.33 billion and a PE ratio of 18.91. The company has a fifty-day moving average of €59.22. The company has a debt ratio of 95.29, a quick ratio of 0.76 and a current ratio of 1.10.

Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured articles

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.